PharMerica Inks $31.5M Deal Over Painkiller Practices
PharMerica Corp. will shell out $31.5 million, including more than $4 million to a whistleblower, to resolve alleged violations of the False Claims Act and the Controlled Substances Act tied to...To view the full article, register now.
Already a subscriber? Click here to view full article